{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T18:14:03Z","timestamp":1767896043476,"version":"3.49.0"},"reference-count":75,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Microbial Pathogenesis"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.micpath.2025.108240","type":"journal-article","created":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T00:25:57Z","timestamp":1766017557000},"page":"108240","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Development of chitosan-functionalized PLGA\/alginate polymeric nanoparticles for controlled doxycycline release in pediatric Streptococcus pneumoniae infections"],"prefix":"10.1016","volume":"211","author":[{"given":"Haiqin","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-2554-0398","authenticated-orcid":false,"given":"Yan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.micpath.2025.108240_bib1","doi-asserted-by":"crossref","first-page":"e450","DOI":"10.1016\/S2666-5247(21)00064-1","article-title":"Antimicrobial resistance in paediatric Streptococcus pneumoniae isolates amid global implementation of pneumococcal conjugate vaccines: a systematic review and meta-regression analysis","volume":"2","author":"Andrejko","year":"2021","journal-title":"Lancet Microbe"},{"key":"10.1016\/j.micpath.2025.108240_bib2","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1055\/s-0029-1202938","article-title":"Streptococcus pneumoniae: epidemiology, risk factors, and strategies for prevention","volume":"30","author":"Lynch","year":"2009","journal-title":"Semin. Respir. Crit. Care Med."},{"key":"10.1016\/j.micpath.2025.108240_bib3","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1128\/CMR.00058-15","article-title":"Biological and epidemiological features of antibiotic-resistant Streptococcus pneumoniae in pre- and post-conjugate vaccine eras: a United States perspective","volume":"29","author":"Kim","year":"2016","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.micpath.2025.108240_bib4","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.jmii.2021.08.002","article-title":"Carriage of Streptococcus pneumoniae in children under five years of age prior to pneumococcal vaccine introduction in Southeast Asia: a systematic review and meta-analysis (2001\u20132019)","volume":"55","author":"Daningrat","year":"2022","journal-title":"J. Microbiol. Immunol. Infect."},{"key":"10.1016\/j.micpath.2025.108240_bib5","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0297041","article-title":"Nasopharyngeal carriage of Streptococcus pneumoniae among children <5 years of age in Indonesia prior to pneumococcal conjugate vaccine introduction","volume":"19","author":"Safari","year":"2024","journal-title":"PLoS One"},{"key":"10.1016\/j.micpath.2025.108240_bib6","unstructured":"G.M. Lee, K. Kleinman, S. Pelton, M. Lipsitch, S.S. Huang, M. Lakoma, M. Dutta-Linn, M. Rett, W.P. Hanage, J.A. Finkelstein, Immunization, antibiotic use, and pneumococcal colonization over a 15-Year period, n.d. http:\/\/pediatrics.aappublications.org\/."},{"key":"10.1016\/j.micpath.2025.108240_bib7","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2021.726740","article-title":"Molecular characterization based on whole-genome sequencing of Streptococcus pneumoniae in children living in Southwest China during 2017-2019","volume":"11","author":"Yan","year":"2021","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.micpath.2025.108240_bib8","doi-asserted-by":"crossref","first-page":"e744","DOI":"10.1016\/S2214-109X(18)30247-X","article-title":"Burden of Streptococcus pneumoniae and Haemophilus influenzae type b disease in children in the era of conjugate vaccines: global, regional, and national estimates for 2000\u201315","volume":"6","author":"Wahl","year":"2018","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.micpath.2025.108240_bib9","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1007\/s40121-021-00544-1","article-title":"Clinical and economic burden of pneumococcal disease due to serotypes contained in Current and investigational pneumococcal conjugate vaccines in children under five years of Age","volume":"10","author":"Wasserman","year":"2021","journal-title":"Infect. Dis. Ther."},{"key":"10.1016\/j.micpath.2025.108240_bib10","doi-asserted-by":"crossref","first-page":"e1485","DOI":"10.1016\/S2214-109X(24)00232-8","article-title":"Re-evaluating the impact and cost-effectiveness of pneumococcal conjugate vaccine introduction in 112 low-income and middle-income countries in children younger than 5 years: a modelling study","volume":"12","author":"Chen","year":"2024","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.micpath.2025.108240_bib11","unstructured":"W.P. Hausdorff, J. Bryant, P.R. Paradiso, G.R. Siber, W.-L. Vaccines, W. Henrietta, P. River, N. York, Which pneumococcal serogroups cause the Most invasive disease: implications for conjugate vaccine formulation and use, Part I, n.d. http:\/\/cid.oxfordjournals.org\/."},{"key":"10.1016\/j.micpath.2025.108240_bib12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000348","article-title":"Systematic evaluation of serotypes causing invasive pneumococcal disease among children under five: the pneumococcal global serotype project","volume":"7","author":"Johnson","year":"2010","journal-title":"PLoS Med."},{"key":"10.1016\/j.micpath.2025.108240_bib13","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/S0140-6736(13)60222-6","article-title":"Global burden of childhood pneumonia and diarrhoea","volume":"381","author":"Fischer Walker","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.micpath.2025.108240_bib14","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/j.cmi.2019.06.030","article-title":"Impact of vaccination on antibiotic usage: a systematic review and meta-analysis","volume":"25","author":"Buckley","year":"2019","journal-title":"Clin. Microbiol. Infection"},{"key":"10.1016\/j.micpath.2025.108240_bib15","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/s41586-020-2238-4","article-title":"Childhood vaccines and antibiotic use in low- and middle-income countries","volume":"581","author":"Lewnard","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.micpath.2025.108240_bib16","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/9977371","article-title":"Multidrug-Resistant bacteria and Enterobacteriaceae count in Abattoir wastes and its receiving waters in limbe municipality, Cameroon: public health implications","volume":"2022","author":"Esemu","year":"2022","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.micpath.2025.108240_bib17","doi-asserted-by":"crossref","DOI":"10.3390\/ph16111615","article-title":"Origin of antibiotics and antibiotic resistance, and their impacts on drug development: a narrative review","volume":"16","author":"Muteeb","year":"2023","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.micpath.2025.108240_bib18","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1002\/der2.49","article-title":"Treating acne with the tetracycline class of antibiotics: a review","volume":"2","author":"Graber","year":"2021","journal-title":"Dermatological Reviews"},{"key":"10.1016\/j.micpath.2025.108240_bib19","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms11040953","article-title":"Antimicrobial drug resistance in poultry production: current status and innovative strategies for bacterial control","volume":"11","author":"Abreu","year":"2023","journal-title":"Microorganisms"},{"key":"10.1016\/j.micpath.2025.108240_bib20","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-78326-1","article-title":"Reducing the effective dose of doxycycline using chitosan silver nanocomposite as a carriers on gram positive and gram-negative bacteria","volume":"14","author":"Mostafa","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.micpath.2025.108240_bib21","article-title":"Antimicrobials and antibiotic-resistant bacteria: a risk to the environment and to public health","volume":"12","author":"Serweci\u0144ska","year":"2020","journal-title":"Water (Switzerland)"},{"key":"10.1016\/j.micpath.2025.108240_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/nano10071403","article-title":"Polymeric nanoparticles for drug delivery: recent developments and future prospects","volume":"10","author":"Begines","year":"2020","journal-title":"Nanomaterials"},{"key":"10.1016\/j.micpath.2025.108240_bib23","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14122728","article-title":"PLGA-Based nanomedicine: history of advancement and development in clinical applications of multiple diseases","volume":"14","author":"Alsaab","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.micpath.2025.108240_bib24","doi-asserted-by":"crossref","DOI":"10.3390\/polym13060904","article-title":"Antimicrobial actions and applications of Chitosan","volume":"13","author":"Ke","year":"2021","journal-title":"Polymers"},{"key":"10.1016\/j.micpath.2025.108240_bib25","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1016\/j.ijbiomac.2017.07.087","article-title":"Chitosan as a bioactive polymer: processing, properties and applications","volume":"105","author":"Muxika","year":"2017","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.micpath.2025.108240_bib26","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/j.jclepro.2016.06.153","article-title":"Application of modified chitosan membrane for microbial fuel cell: roles of proton carrier site and positive charge","volume":"142","author":"Srinophakun","year":"2017","journal-title":"J. Clean. Prod."},{"key":"10.1016\/j.micpath.2025.108240_bib27","doi-asserted-by":"crossref","DOI":"10.3390\/polym11111837","article-title":"The use of chitosan, alginate, and pectin in the biomedical and food sector-biocompatibility, bioadhesiveness, and biodegradability","volume":"11","author":"Martau","year":"2019","journal-title":"Polymers"},{"key":"10.1016\/j.micpath.2025.108240_bib28","first-page":"1","article-title":"Alginate: from food industry to biomedical applications and management of metabolic disorders","volume":"12","author":"Puscaselu","year":"2020","journal-title":"Polymers"},{"key":"10.1016\/j.micpath.2025.108240_bib29","doi-asserted-by":"crossref","first-page":"4672","DOI":"10.1039\/D1CS00574J","article-title":"Modulation of engineered nanomaterial interactions with organ barriers for enhanced drug transport","volume":"52","author":"Lenders","year":"2023","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.micpath.2025.108240_bib30","first-page":"1","article-title":"A review on Chitosan's uses as biomaterial: tissue engineering, drug delivery systems and cancer treatment","volume":"13","author":"Victor","year":"2020","journal-title":"Materials"},{"key":"10.1016\/j.micpath.2025.108240_bib31","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2023.1095166","article-title":"The dilemma of improving rational antibiotic use in pediatric community-acquired pneumonia","volume":"11","author":"Nguyen","year":"2023","journal-title":"Front. Pediatr."},{"key":"10.1016\/j.micpath.2025.108240_bib32","doi-asserted-by":"crossref","DOI":"10.3390\/nano11071850","article-title":"pH-responsive chitosan\/alginate polyelectrolyte complexes on electrospun PLGA nanofibers for controlled drug release","volume":"11","author":"Schoeller","year":"2021","journal-title":"Nanomaterials"},{"key":"10.1016\/j.micpath.2025.108240_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms22062792","article-title":"Biodegradable nanoparticles-loaded plga microcapsule for the enhanced encapsulation efficiency and controlled release of hydrophilic drug","volume":"22","author":"Ryu","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.micpath.2025.108240_bib34","doi-asserted-by":"crossref","DOI":"10.3390\/md20030156","article-title":"Enhancing stability and mucoadhesive properties of Chitosan nanoparticles by surface modification with sodium alginate and polyethylene glycol for potential oral Mucosa vaccine delivery","volume":"20","author":"Amin","year":"2022","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.micpath.2025.108240_bib35","doi-asserted-by":"crossref","first-page":"5021","DOI":"10.2147\/IJN.S469572","article-title":"Chitosan\/Alginate-Based nanoparticles for antibacterial agents delivery","volume":"19","author":"Wathoni","year":"2024","journal-title":"Int J Nanomedicine"},{"key":"10.1016\/j.micpath.2025.108240_bib36","doi-asserted-by":"crossref","DOI":"10.3390\/ph17121742","article-title":"Breath and beyond: advances in nanomedicine for oral and intranasal aerosol drug delivery","volume":"17","author":"Du","year":"2024","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.micpath.2025.108240_bib37","doi-asserted-by":"crossref","DOI":"10.3892\/ijo.2024.5626","article-title":"A novel therapeutic outlook: classification, applications and challenges of inhalable micron\/nanoparticle drug delivery systems in lung cancer","volume":"64","author":"Xie","year":"2024","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.micpath.2025.108240_bib38","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.addr.2014.05.017","article-title":"Delivery strategies for sustained drug release in the lungs","volume":"75","author":"Loira-Pastoriza","year":"2014","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.micpath.2025.108240_bib39","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1016\/j.addr.2006.07.012","article-title":"In vivo, in vitro and ex vivo models to assess pulmonary absorption and disposition of inhaled therapeutics for systemic delivery","volume":"58","author":"Sakagami","year":"2006","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.micpath.2025.108240_bib40","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23169035","article-title":"Alginate as a promising biopolymer in drug delivery and wound healing: a review of the state-of-the-art","volume":"23","author":"Abourehab","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.micpath.2025.108240_bib41","doi-asserted-by":"crossref","DOI":"10.3390\/md20080522","article-title":"Mucoadhesive marine polysaccharides","volume":"20","author":"Yermak","year":"2022","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.micpath.2025.108240_bib42","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics11080379","article-title":"Alginate\/chitosan particle-based drug delivery systems for pulmonary applications","volume":"11","author":"Hill","year":"2019","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.micpath.2025.108240_bib43","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.procbio.2020.04.003","article-title":"Biologically-relevant interactions, phase separations and thermodynamics of chitosan\u2013mucin binary systems","volume":"94","author":"Ahmad","year":"2020","journal-title":"Process Biochem."},{"key":"10.1016\/j.micpath.2025.108240_bib44","doi-asserted-by":"crossref","DOI":"10.3390\/biomimetics4020032","article-title":"Interaction between Chitosan and Mucin: fundamentals and applications","volume":"4","author":"Collado-Gonz\u00e1lez","year":"2019","journal-title":"Biomimetics"},{"key":"10.1016\/j.micpath.2025.108240_bib45","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15020606","article-title":"Chitosan surface-modified PLGA nanoparticles loaded with cranberry powder extract as a potential oral delivery platform for targeting Colon cancer cells","volume":"15","author":"Mostafa","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.micpath.2025.108240_bib46","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.colsurfb.2012.04.016","article-title":"PLGA-based nanoparticles: effect of chitosan in the aggregate stabilization. A dielectric relaxation spectroscopy study","volume":"97","author":"Chronopoulou","year":"2012","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.micpath.2025.108240_bib47","doi-asserted-by":"crossref","DOI":"10.3390\/md20030156","article-title":"Enhancing stability and mucoadhesive properties of Chitosan nanoparticles by surface modification with sodium alginate and polyethylene glycol for potential oral Mucosa vaccine delivery","volume":"20","author":"Amin","year":"2022","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.micpath.2025.108240_bib48","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ejpb.2017.12.020","article-title":"Development of a non-toxic and non-denaturing formulation process for encapsulation of SDF-1\u03b1 into PLGA\/PEG-PLGA nanoparticles to achieve sustained release","volume":"125","author":"Haji Mansor","year":"2018","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.micpath.2025.108240_bib49","author":"Bernkop-Schnurch"},{"key":"10.1016\/j.micpath.2025.108240_bib50","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics13101686","article-title":"Chitosan nanoparticles at the biological interface: implications for drug delivery","volume":"13","author":"Aibani","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.micpath.2025.108240_bib51","doi-asserted-by":"crossref","DOI":"10.3390\/md18120605","article-title":"The application of mucoadhesive chitosan nanoparticles in nasal drug delivery","volume":"18","author":"Shim","year":"2020","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.micpath.2025.108240_bib52","doi-asserted-by":"crossref","first-page":"9035","DOI":"10.3390\/ijms23169035","article-title":"Alginate as a promising biopolymer in drug delivery and wound healing: a review of the state-of-the-art","volume":"23","author":"Abourehab","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.micpath.2025.108240_bib53","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.ijmm.2017.09.016","article-title":"Biofilms: survival and defense strategy for pathogens","volume":"307","author":"Kumar","year":"2017","journal-title":"International Journal of Medical Microbiology"},{"key":"10.1016\/j.micpath.2025.108240_bib54","doi-asserted-by":"crossref","first-page":"5061","DOI":"10.2147\/IDR.S379502","article-title":"Biofilm-Associated multi-drug resistance in hospital-acquired infections: a review","volume":"15","author":"Assefa","year":"2022","journal-title":"Infect. Drug Resist."},{"key":"10.1016\/j.micpath.2025.108240_bib55","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms10020303","article-title":"Development of antibiofilm therapeutics strategies to overcome antimicrobial drug resistance","volume":"10","author":"Nadar","year":"2022","journal-title":"Microorganisms"},{"key":"10.1016\/j.micpath.2025.108240_bib56","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.colsurfb.2017.07.038","article-title":"Recent applications of PLGA based nanostructures in drug delivery","volume":"159","author":"Mir","year":"2017","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.micpath.2025.108240_bib57","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.trac.2015.06.014","article-title":"PLGA-based nanoparticles: a new paradigm in biomedical applications","volume":"80","author":"Sharma","year":"2016","journal-title":"TrAC, Trends Anal. Chem."},{"key":"10.1016\/j.micpath.2025.108240_bib58","doi-asserted-by":"crossref","DOI":"10.3390\/polym11020304","article-title":"Chitosan-modified PLGA nanoparticles for control-released drug delivery","volume":"11","author":"Lu","year":"2019","journal-title":"Polymers"},{"key":"10.1016\/j.micpath.2025.108240_bib59","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/polym13050724","article-title":"Polymeric nanoparticles for antimicrobial therapies: an up-to-date overview","volume":"13","author":"Spirescu","year":"2021","journal-title":"Polymers"},{"key":"10.1016\/j.micpath.2025.108240_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.134977","article-title":"Unleashing the power of polymeric nanoparticles \u2014 creative triumph against antibiotic resistance: a review","volume":"278","author":"Naik","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.micpath.2025.108240_bib61","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2020.00952","article-title":"Innovative strategies toward the disassembly of the EPS matrix in bacterial biofilms","volume":"11","author":"Pinto","year":"2020","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.micpath.2025.108240_bib62","doi-asserted-by":"crossref","DOI":"10.3390\/pr8091173","article-title":"Antibacterial activity of chitosan nanoparticles: a review","volume":"8","author":"Chandrasekaran","year":"2020","journal-title":"Processes"},{"key":"10.1016\/j.micpath.2025.108240_bib63","first-page":"2411","article-title":"Synergetic effects of doxycycline-loaded chitosan nanoparticles for improving drug delivery and efficacy","volume":"7","author":"Cover","year":"2012","journal-title":"Int J Nanomedicine"},{"key":"10.1016\/j.micpath.2025.108240_bib64","first-page":"3187","article-title":"The synergistic effects of chitosan-alginate nanoparticles loaded with doxycycline antibiotic against multidrug resistant proteus mirabilis, Escherichia coli and enterococcus faecalis","volume":"61","author":"Kadhum","year":"2020","journal-title":"Iraqi J. Sci."},{"key":"10.1016\/j.micpath.2025.108240_bib65","first-page":"475","article-title":"Streptococcus pneumoniae biofilms and human infectious diseases: a review","author":"Zomuansangi","year":"2022","journal-title":"Understanding Microbial Biofilms: Fundamentals to Applications"},{"key":"10.1016\/j.micpath.2025.108240_bib66","article-title":"Streptococcus pneumoniae biofilm formation and dispersion during colonization and disease","volume":"4","author":"Chao","year":"2014","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.micpath.2025.108240_bib67","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15041142","article-title":"Alginate-Based materials loaded with nanoparticles in wound healing","volume":"15","author":"Froelich","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.micpath.2025.108240_bib68","unstructured":"1 (2), (n.d.)."},{"key":"10.1016\/j.micpath.2025.108240_bib69","doi-asserted-by":"crossref","DOI":"10.2174\/0929867324666170309123351","article-title":"Polysaccharide-Based materials associated with or coordinated to gold nanoparticles: synthesis and medical application","volume":"24","author":"Facchi","year":"2017","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.micpath.2025.108240_bib70","doi-asserted-by":"crossref","first-page":"17902","DOI":"10.1021\/acsami.9b05787","article-title":"Local Photothermal\/Photodynamic synergistic therapy by disrupting bacterial membrane to accelerate reactive oxygen Species permeation and protein leakage","volume":"11","author":"Mao","year":"2019","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.micpath.2025.108240_bib71","doi-asserted-by":"crossref","DOI":"10.3390\/nano12020186","article-title":"Applications of chitosan-alginate-based Nanoparticles\u2014 an up-to-date review","volume":"12","author":"Niculescu","year":"2022","journal-title":"Nanomaterials"},{"key":"10.1016\/j.micpath.2025.108240_bib72","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1016\/j.actbio.2014.01.033","article-title":"Polymeric nanoparticles for pulmonary protein and DNA delivery","volume":"10","author":"Menon","year":"2014","journal-title":"Acta Biomater."},{"key":"10.1016\/j.micpath.2025.108240_bib73","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1002\/jbm.a.33000","article-title":"PLGA-chitosan\/PLGA-alginate nanoparticle blends as biodegradable colloidal gels for seeding human umbilical cord mesenchymal stem cells","volume":"96 A","author":"Wang","year":"2011","journal-title":"J. Biomed. Mater. Res."},{"key":"10.1016\/j.micpath.2025.108240_bib74","doi-asserted-by":"crossref","first-page":"3515","DOI":"10.1021\/acsabm.3c00984","article-title":"Alginate-Chitosan biodegradable and biocompatible based hydrogel for breast cancer immunotherapy and diagnosis: a comprehensive review","volume":"7","author":"Patra","year":"2024","journal-title":"ACS Appl. Bio Mater."},{"key":"10.1016\/j.micpath.2025.108240_bib75","doi-asserted-by":"crossref","first-page":"5021","DOI":"10.2147\/IJN.S469572","article-title":"Chitosan\/Alginate-Based nanoparticles for antibacterial agents delivery","volume":"19","author":"Wathoni","year":"2024","journal-title":"Int J Nanomedicine"}],"container-title":["Microbial Pathogenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401025009659?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401025009659?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T12:28:55Z","timestamp":1767875335000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0882401025009659"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":75,"alternative-id":["S0882401025009659"],"URL":"https:\/\/doi.org\/10.1016\/j.micpath.2025.108240","relation":{},"ISSN":["0882-4010"],"issn-type":[{"value":"0882-4010","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of chitosan-functionalized PLGA\/alginate polymeric nanoparticles for controlled doxycycline release in pediatric Streptococcus pneumoniae infections","name":"articletitle","label":"Article Title"},{"value":"Microbial Pathogenesis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.micpath.2025.108240","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108240"}}